Scilex Holding Company (NASDAQ:SCLX) does about 1.13M shares in volume on a normal day but saw 1547670 shares change hands in Tuesday trading. The company now has a market cap of 349.70M USD. Its current market price is $1.93, marking an increase of 2.66% compared to the previous close of $1.88. The 52 week high reached by this stock is $6.55 whilst the lowest price level in 52 weeks is $0.73.
Scilex Holding Company (SCLX) has a 20-day trading average at $1.5707 and the current price is -70.53% off the 52-week high compared with 163.81% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.1972 and its 200-day simple moving average is $1.4671. If we look at the stock’s price movements over the week, volatility stands at 12.74%, which increases to 14.39% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 62.43 to suggest the stock is neutral.
The consensus objective for the share price is $7.25, suggesting that the stock has a potential upside of 73.38% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 13, 2024 when Rodman & Renshaw initiated the stock to “Buy” and issued a price target of $13. B. Riley Securities initiated its price target at $4.
Scilex Holding Company (SCLX) stock is up 30.41% over the week and 78.70% over the past month. Its price is -5.39% year-to-date and -65.35% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -0.63 below consensus estimates by -0.46. The company’s next earnings report forecasts estimating quarterly EPS at -0.2 and -0.74 for whole year. Expected sales for next quarter are $16.03M, which analysts say will come at $60.1M for the current fiscal year and next year at $89.18M. In addition, estimates put the company’s current quarterly revenue at an average of $13.17M.
To reach the target analysts have set, the stock logically needs to grow 73.38 percent from here.
The company has a return on equity of -163.31%. The beta has a value of 1.23. Price to sales ratio is 7.43.
